Uridine diphosphate N-acetylglucosamine: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
'''Uridine diphosphate N-acetylglucosamine''' (UDP-GlcNAc) is a | == Uridine diphosphate N-acetylglucosamine == | ||
[[File:UDP-N-acetylglucosamine.png|thumb|right|Structure of UDP-N-acetylglucosamine]] | |||
'''Uridine diphosphate N-acetylglucosamine''' ('''UDP-GlcNAc''') is a nucleotide sugar that plays a crucial role in the metabolism of carbohydrates. It is a key substrate for the synthesis of glycoproteins and glycolipids. | |||
== Structure == | == Structure == | ||
UDP-GlcNAc is composed of the nucleotide [[uridine]] diphosphate (UDP) linked to N-acetylglucosamine (GlcNAc), a derivative of [[glucosamine]]. The structure of UDP-GlcNAc includes a uracil base, a ribose sugar, and a diphosphate group, which is connected to the N-acetylglucosamine moiety. | |||
UDP-GlcNAc is composed of [[uridine | |||
== Biosynthesis == | == Biosynthesis == | ||
The biosynthesis of UDP-GlcNAc occurs in the [[cytosol]] of cells. It begins with the conversion of [[fructose-6-phosphate]] to glucosamine-6-phosphate by the enzyme [[glutamine--fructose-6-phosphate aminotransferase]]. This is followed by acetylation to form N-acetylglucosamine-6-phosphate, which is then converted to N-acetylglucosamine-1-phosphate. Finally, the enzyme [[UDP-N-acetylglucosamine pyrophosphorylase]] catalyzes the formation of UDP-GlcNAc from N-acetylglucosamine-1-phosphate and UTP. | |||
The biosynthesis of UDP-GlcNAc begins with the conversion of [[fructose 6-phosphate]] to | |||
== Function == | == Function == | ||
UDP-GlcNAc serves as a donor of N-acetylglucosamine in the synthesis of [[glycoproteins]] and [[glycolipids]]. It is involved in the [[O-GlcNAcylation]] of proteins, a post-translational modification that regulates various cellular processes. UDP-GlcNAc is also a precursor in the biosynthesis of [[hyaluronic acid]], [[heparan sulfate]], and [[chondroitin sulfate]]. | |||
UDP-GlcNAc serves as a donor of N-acetylglucosamine in the | |||
== Clinical significance == | == Clinical significance == | ||
Alterations in UDP-GlcNAc metabolism have been linked to several diseases, including [[diabetes mellitus]], [[cancer]], and [[congenital disorders of glycosylation]]. The regulation of UDP-GlcNAc levels is critical for maintaining normal cellular function and homeostasis. | |||
== Related pages == | |||
* [[Glycosylation]] | |||
* [[Nucleotide sugar]] | |||
* [[Glycoprotein]] | |||
== | == References == | ||
{{Reflist}} | |||
[[Category:Biochemistry]] | [[Category:Biochemistry]] | ||
[[Category: | [[Category:Nucleotides]] | ||
Revision as of 16:17, 9 February 2025
Uridine diphosphate N-acetylglucosamine

Uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) is a nucleotide sugar that plays a crucial role in the metabolism of carbohydrates. It is a key substrate for the synthesis of glycoproteins and glycolipids.
Structure
UDP-GlcNAc is composed of the nucleotide uridine diphosphate (UDP) linked to N-acetylglucosamine (GlcNAc), a derivative of glucosamine. The structure of UDP-GlcNAc includes a uracil base, a ribose sugar, and a diphosphate group, which is connected to the N-acetylglucosamine moiety.
Biosynthesis
The biosynthesis of UDP-GlcNAc occurs in the cytosol of cells. It begins with the conversion of fructose-6-phosphate to glucosamine-6-phosphate by the enzyme glutamine--fructose-6-phosphate aminotransferase. This is followed by acetylation to form N-acetylglucosamine-6-phosphate, which is then converted to N-acetylglucosamine-1-phosphate. Finally, the enzyme UDP-N-acetylglucosamine pyrophosphorylase catalyzes the formation of UDP-GlcNAc from N-acetylglucosamine-1-phosphate and UTP.
Function
UDP-GlcNAc serves as a donor of N-acetylglucosamine in the synthesis of glycoproteins and glycolipids. It is involved in the O-GlcNAcylation of proteins, a post-translational modification that regulates various cellular processes. UDP-GlcNAc is also a precursor in the biosynthesis of hyaluronic acid, heparan sulfate, and chondroitin sulfate.
Clinical significance
Alterations in UDP-GlcNAc metabolism have been linked to several diseases, including diabetes mellitus, cancer, and congenital disorders of glycosylation. The regulation of UDP-GlcNAc levels is critical for maintaining normal cellular function and homeostasis.
Related pages
References
<references group="" responsive="1"></references>